Search Results
SMARCA4
Targeting SMARCA4 mutations in lung cancer
Bio SB - 2021 New BRG-1 / SMARCA4 Antibody for IHC
Phase I trial of PRT3789, a SMARCA2 degrader, in SMARCA4-mutated solid tumors
Defining the first bona fide cell model for SMARCA4-deficient, undifferentiated tumor.
SMARCA4-Deficient Carcinoma of the Gastroesophageal Junction
Molecular Tumor Board - SMARCA4 mutation in Lung Cancer
Impact of chromosome 19p gene deletion on immunotherapy for NSCLC
SCCOHT/SMARCA4 Patient & Family information session
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
August 27, 2022, Revolution Cancer International Molecular Tumor Board -GSK, SMARCA4, MTAP, NSCLC
Pattern 5 – Nodules, SMARC A4 Deficient Sarcoma (Top 25 Pearls Series, Topic 5, Pearl 2)
